Pharmaceutical Productions, Inc.
USPTO PatentsView assignee record - 12 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Pharmaceutical ranks #23,187 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 3 technology areas.
- #23,187
- of 49,997 US assignees by volume
- 19th percentile
- by Innovation Score (26.0/100)
- 14.6
- avg claims per patent
- -62%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R23187 · US Corporation #23,187 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #23,187/49,997
- PHOTO-FINISH Performance Indicator
- CPC-NARROW A61K · 3 areas
- INNOV-THIN 26.0/100
- CLAIMS-RICH 14.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -62% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Performance Indicator, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Pharmaceutical’s 26.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Pharmaceutical
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Pharmaceutical… · this assignee 26
Pharmaceutical… · this assignee
26 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Pharmaceutical's Innovation Score is 26.0/100 (19th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Pharmaceutical?
Each dot is one of Pharmaceutical’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pharmaceutical’s own 14.6 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Pharmaceutical's grants concentrate
Pharmaceutical Productions, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2017. By volume, Pharmaceutical sits between Performance Indicator, LLC and Philo, Inc..
Pharmaceutical's three-year grant acceleration
Pharmaceutical Productions, Inc. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Pharmaceutical's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Performance Indic…
Performance Indicator, LLC
12 patents
- Performance Plants
Performance Plants Inc.
12 patents
- Pernix Sleep
Pernix Sleep, Inc.
12 patents
- Petram
Petram Technologies, Inc.
12 patents
- Phase 5 Weapon Sy…
Phase 5 Weapon Systems Inc.
12 patents
- Phaserx
PhaseRx, Inc.
12 patents
- Phillips Connect
Phillips Connect Technologies LLC
12 patents
- Philo
Philo, Inc.
12 patents
- Pharmaceutical Pr… ◀
Pharmaceutical Productions, Inc.
12 patents
What this shows Pharmaceutical holds 12 patents at rank #23,203, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Pharmaceutical
By rank, the assignees closest to #23,203 in granted patent volume.
- Performance Indicator, LLC #23,199 · 12 patents
- Performance Plants Inc. #23,200 · 12 patents
- Pernix Sleep, Inc. #23,201 · 12 patents
- Petram Technologies, Inc. #23,202 · 12 patents
- Phase 5 Weapon Systems Inc. #23,204 · 12 patents
- PhaseRx, Inc. #23,205 · 12 patents
- Phillips Connect Technologies LLC #23,206 · 12 patents
- Philo, Inc. #23,207 · 12 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Pharmaceutical's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Pharmaceutical's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 19th percentile higher than 19% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 16.7% |
| 2016 | 4 | 33.3% |
| 2017 | 1 | 8.3% |
| 2019 | 1 | 8.3% |
| 2021 | 2 | 16.7% |
| 2023 | 1 | 8.3% |
| 2025partial year | 1 | 8.3% |
Which technologies does Pharmaceutical Productions, Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Pharmaceutical Productions, Inc.'s patent record in context - here's where to go next.
- Pharmaceutical Productions, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #23,187 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Pharmaceutical Productions, Inc. against Performance Indicator, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.